Aurie announced that the Aurie Reusable No-Touch Intermittent Catheter System™ has been granted marketing authorization from the U.S. Food and Drug Administration (FDA) through the Class II De Novo ...

Aurie received FDA clearance to market a reusable device designed to lower infection risk for long-term users.

Aurie has announced that the Aurie Reusable No-Touch Intermittent Catheter System has been granted marketing authorization from the U.S. Food and Drug Administration (FDA) through the Class II De Novo ...

The DoJ secured record-breaking False Claims Act recoveries of $6.8 billion in fiscal year 2025, with $76 million from the ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Intrathecal baclofen (ITB) therapy is an established treatment for severe refractory spasticity. Although a positive ITB ...

Urinary bladder paragangliomas (UBPGLs) are rare neuroendocrine tumours, comprising <0.05% of bladder neoplasms. We report a case of a male in his early 30s presenting with persistent lower abdominal ...

A continuous quality improvement approach helped identify and intervene in vascular access issues for patients on home ...

Over the last several years, Apple has dramatically improved how it handles lithium-ion battery charging in iPhones, iPads, Macs, and Apple Watches. Across multiple system releases, the company moved ...

A study conducted during COVID-19 pandemic explored the effects of extending the intervals between implanted vascular access port flushing.

Intermittent fasting has become one of the most talked-about weight loss trends in recent years, promising dramatic results with simple changes to when you eat. But a major Cochrane review suggests ...